Inogen (INGN) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sanara MedTech (SMTI) has outperformed Inogen (INGN) over the past year, gaining 8.4% versus a loss of 31.6%. Over five years, SMTI leads with a +6.3% price change compared with -85.4% for INGN. Sanara MedTech is the larger company by market cap ($322.4 million vs $161.1 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INGN | SMTI |
|---|---|---|
| Share price | $6.07 | $35.09 |
| Market cap | $161.09M | $322.41M |
| 1-day change | +2.19% | +0.11% |
| YTD return | -11.61% | +50.11% |
| 1-year return | -31.65% | +8.41% |
| 5-year return | -85.45% | +6.28% |
| Forward P/E | — | 64.98 |
| EPS (TTM) | $-0.92 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.13 | $35.34 |
| 52-week low | $5.05 | $16.05 |
| Distance from 52-week high | -33.52% | -0.71% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +97.69% | -0.26% |
| Average volume | 294.94K | 280.40K |
| Shares outstanding | 26.54M | 9.19M |
| Employees | 753 | 108 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sanara MedTech is about 2.0 times larger than Inogen by market value ($322.41M vs $161.09M).
- SMTI has outperformed INGN by 40.1 percentage points over the past year.
About Inogen
INGN stock →Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Health Care · Industrial Specialties · 753 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
INGN vs SMTI FAQ
Which is bigger, Inogen or Sanara MedTech?
Sanara MedTech (SMTI) is larger, with a market capitalization of $322.41M compared with $161.09M for Inogen (INGN).
Which stock has performed better over the past year, INGN or SMTI?
SMTI returned +8.41% over the past 12 months, compared with -31.65% for INGN (price return, excluding dividends). Past performance does not predict future results.
Are Inogen and Sanara MedTech in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.